Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Evaluate the Safety and Clinical Activity of UCART123 in Patients With BPDCN (ABC123)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03203369
Recruitment Status : Terminated (The trial was discontinued due to sponsor's decision and not a consequence of any safety concern.)
First Posted : June 29, 2017
Last Update Posted : July 31, 2019
Sponsor:
Information provided by (Responsible Party):
Cellectis S.A.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 27, 2019
Actual Study Completion Date : June 27, 2019